New sleep tool could help kids with chronic illnesses get better rest

NCT ID NCT07210476

Recruiting now Knowledge-focused Sponsor: Marmara University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is translating a sleep screening questionnaire into Turkish and testing how well it works for children with complex chronic conditions. Researchers will enroll 330 children and teens, tracking their sleep at home and during stays in the pediatric intensive care unit. The goal is to create a reliable tool to identify sleep problems in this vulnerable group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide a reliable Turkish-language tool to screen for sleep problems in children with complex chronic conditions, helping doctors identify and address sleep issues earlier.
What could go wrong: This is an observational study focused on translating and validating a questionnaire, not testing a treatment. The tool may not work equally well for all children or settings, and results may not apply outside Turkey.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC CONDITIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Disease sleep disorder sleep-wake disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC CONDITIONS PEDIATRIC INTENSIVE CARE SLEEP SLEEP DISORDER (DISORDER)

Contacts and locations

Locations

Marmara University School of Medicine, Department of Pediatrics, Division of Social Pediatrics
RECRUITING

Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.